Abstract
The 2023 international guideline for the assessment and management of polycystic ovary syndrome introduces several key changes. The updated guideline emphasises holistic patient care that addresses the associated cardiometabolic risks and complications and psychosocial challenges.
| Original language | English |
|---|---|
| Pages (from-to) | 26-33 |
| Number of pages | 8 |
| Journal | Medicine Today |
| Volume | 25 |
| Issue number | 1-2 |
| Publication status | Published - Jan 2024 |